Clinical Trials Logo

Hypervascular Tumors clinical trials

View clinical trials related to Hypervascular Tumors.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06170619 Not yet recruiting - Bleeding Clinical Trials

Obsidio™ Conformable Embolic Registry

OCCLUDE
Start date: May 2024
Phase:
Study type: Observational [Patient Registry]

OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.